141 related articles for article (PubMed ID: 29280317)
1. Selective Cell Penetrating Peptide-Functionalized Polymersomes Mediate Efficient and Targeted Delivery of Methotrexate Disodium to Human Lung Cancer In Vivo.
Yang W; Xia Y; Fang Y; Meng F; Zhang J; Cheng R; Deng C; Zhong Z
Adv Healthc Mater; 2018 Apr; 7(7):e1701135. PubMed ID: 29280317
[TBL] [Abstract][Full Text] [Related]
2. Lung cancer specific and reduction-responsive chimaeric polymersomes for highly efficient loading of pemetrexed and targeted suppression of lung tumor in vivo.
Yang W; Yang L; Xia Y; Cheng L; Zhang J; Meng F; Yuan J; Zhong Z
Acta Biomater; 2018 Apr; 70():177-185. PubMed ID: 29410335
[TBL] [Abstract][Full Text] [Related]
3. Robust, tumor-homing and redox-sensitive polymersomal doxorubicin: A superior alternative to Doxil and Caelyx?
Zou Y; Meng F; Deng C; Zhong Z
J Control Release; 2016 Oct; 239():149-58. PubMed ID: 27569664
[TBL] [Abstract][Full Text] [Related]
4. Granzyme B-loaded, cell-selective penetrating and reduction-responsive polymersomes effectively inhibit progression of orthotopic human lung tumor in vivo.
Yang W; Wei Y; Yang L; Zhang J; Zhong Z; Storm G; Meng F
J Control Release; 2018 Nov; 290():141-149. PubMed ID: 30312720
[TBL] [Abstract][Full Text] [Related]
5. EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo.
Fang Y; Yang W; Cheng L; Meng F; Zhang J; Zhong Z
Acta Biomater; 2017 Dec; 64():323-333. PubMed ID: 29030307
[TBL] [Abstract][Full Text] [Related]
6. ATN-161 Peptide Functionalized Reversibly Cross-Linked Polymersomes Mediate Targeted Doxorubicin Delivery into Melanoma-Bearing C57BL/6 Mice.
Zhang N; Xia Y; Zou Y; Yang W; Zhang J; Zhong Z; Meng F
Mol Pharm; 2017 Aug; 14(8):2538-2547. PubMed ID: 28005375
[TBL] [Abstract][Full Text] [Related]
7. Selective Cell Penetrating Peptide-Functionalized Envelope-Type Chimeric Lipopepsomes Boost Systemic RNAi Therapy for Lung Tumors.
Qiu M; Ouyang J; Wei Y; Zhang J; Lan Q; Deng C; Zhong Z
Adv Healthc Mater; 2019 Aug; 8(16):e1900500. PubMed ID: 31231966
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate Gold Nanocarriers: Loading and Release Study: Its Activity in Colon and Lung Cancer Cells.
Álvarez-González B; Rozalen M; Fernández-Perales M; Álvarez MA; Sánchez-Polo M
Molecules; 2020 Dec; 25(24):. PubMed ID: 33371436
[TBL] [Abstract][Full Text] [Related]
9. Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo.
Wei Y; Gu X; Sun Y; Meng F; Storm G; Zhong Z
J Control Release; 2020 Mar; 319():407-415. PubMed ID: 31923538
[TBL] [Abstract][Full Text] [Related]
10. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
11. Dual-ligand modified liposomes provide effective local targeted delivery of lung-cancer drug by antibody and tumor lineage-homing cell-penetrating peptide.
Lin C; Zhang X; Chen H; Bian Z; Zhang G; Riaz MK; Tyagi D; Lin G; Zhang Y; Wang J; Lu A; Yang Z
Drug Deliv; 2018 Nov; 25(1):256-266. PubMed ID: 29334814
[TBL] [Abstract][Full Text] [Related]
12. Orthogonally functionalized nanoscale micelles for active targeted codelivery of methotrexate and mitomycin C with synergistic anticancer effect.
Li Y; Lin J; Wu H; Chang Y; Yuan C; Liu C; Wang S; Hou Z; Dai L
Mol Pharm; 2015 Mar; 12(3):769-82. PubMed ID: 25625539
[TBL] [Abstract][Full Text] [Related]
13. [Chiral selectivity in differentiation of lung cancer A549 cell to vascular endothelial cells after drug resistance induced by D-or L-methotrexate enantiomers].
He XD; Hu SL; Shen ZJ; Tao SN; Dong L; Zhu YY; Li M
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):690-4. PubMed ID: 19595065
[TBL] [Abstract][Full Text] [Related]
14. Efficient and Targeted Suppression of Human Lung Tumor Xenografts in Mice with Methotrexate Sodium Encapsulated in All-Function-in-One Chimeric Polymersomes.
Yang W; Zou Y; Meng F; Zhang J; Cheng R; Deng C; Zhong Z
Adv Mater; 2016 Oct; 28(37):8234-8239. PubMed ID: 27383234
[TBL] [Abstract][Full Text] [Related]
15. Self-assembled peptide nanoparticles for efficient delivery of methotrexate into cancer cells.
Zakeri-Milani P; Shirani A; Nokhodchi A; Mussa Farkhani S; Mohammadi S; Shahbazi Mojarrad J; Mahmoudian M; Gholikhani T; Farshbaf M; Valizadeh H
Drug Dev Ind Pharm; 2020 Apr; 46(4):521-530. PubMed ID: 32116040
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
17. Folate-targeted polymersomes loaded with both paclitaxel and doxorubicin for the combination chemotherapy of hepatocellular carcinoma.
Zhu D; Wu S; Hu C; Chen Z; Wang H; Fan F; Qin Y; Wang C; Sun H; Leng X; Kong D; Zhang L
Acta Biomater; 2017 Aug; 58():399-412. PubMed ID: 28627436
[TBL] [Abstract][Full Text] [Related]
18. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
19. HER2-Specific Reduction-Sensitive Immunopolymersomes with High Loading of Epirubicin for Targeted Treatment of Ovarian Tumor.
Ding L; Gu W; Zhang Y; Yue S; Sun H; Cornelissen JJLM; Zhong Z
Biomacromolecules; 2019 Oct; 20(10):3855-3863. PubMed ID: 31513391
[TBL] [Abstract][Full Text] [Related]
20. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy.
Gao H; Zhang Q; Yang Y; Jiang X; He Q
Int J Pharm; 2015 Jan; 478(1):240-250. PubMed ID: 25448586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
